GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nang Kuang Pharmaceutical Co 1752.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

29.85

+0.17%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 2.16bn

FY2016FY2025

Net income

TWD 243.9m

FY2016FY2025

Free cash flow

TWD 183.0m

FY2016FY2025

Shareholders' equity

TWD 2.48bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 2.16bnTWD 2.20bnTWD 2.15bnTWD 1.94bnTWD 1.78bnTWD 1.75bnTWD 1.76bnTWD 1.54bnTWD 1.50bnTWD 1.55bn
Research and developmentTWD 169.7mTWD 169.4mTWD 164.1mTWD 143.8mTWD 134.0mTWD 159.8mTWD 130.8mTWD 154.7mTWD 135.8mTWD 116.4m
Operating incomeTWD 295.7mTWD 307.5mTWD 259.9mTWD 417.7mTWD 256.4mTWD 225.2mTWD 248.0mTWD 127.6mTWD 161.0mTWD 229.8m
Net incomeTWD 243.9mTWD 243.4mTWD 198.4mTWD 352.0mTWD 196.1mTWD 183.4mTWD 217.4mTWD 101.2mTWD 185.8mTWD 225.5m
Diluted earnings per share2.432.401.963.481.931.812.161.001.832.23

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 3.82bnTWD 3.81bnTWD 3.86bnTWD 3.58bnTWD 3.43bnTWD 3.26bnTWD 3.29bnTWD 3.03bnTWD 3.33bnTWD 3.17bn
Cash and short-term investmentsTWD 345.7mTWD 303.4mTWD 378.5mTWD 402.5m——————
Total liabilitiesTWD 1.33bnTWD 1.39bnTWD 1.48bnTWD 1.17bnTWD 1.19bnTWD 1.06bnTWD 1.10bnTWD 974.6mTWD 1.19bnTWD 1.05bn
DebtTWD 656.0mTWD 638.0mTWD 606.0mTWD 409.1mTWD 37.5mTWD 50.0mTWD 476.0mTWD 476.2mTWD 787.9mTWD 760.3m
Shareholders' equityTWD 2.48bnTWD 2.42bnTWD 2.38bnTWD 2.41bnTWD 2.24bnTWD 2.20bnTWD 2.19bnTWD 2.05bnTWD 2.14bnTWD 2.12bn
Shares outstanding100m101m101m101m101m101m101m101m101m101m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 464.1mTWD 466.4mTWD 342.6mTWD 369.2mTWD 556.6mTWD 151.0mTWD 386.2mTWD 366.1mTWD 322.7mTWD 405.0m
Capital spending−TWD 281.0m−TWD 525.9m−TWD 300.7m−TWD 94.2m−TWD 159.7m−TWD 90.1m−TWD 75.0m−TWD 155.3m−TWD 207.4m−TWD 229.4m
Free cash flowTWD 183.0m−TWD 59.5mTWD 41.9mTWD 275.0mTWD 396.9mTWD 60.9mTWD 311.2mTWD 210.8mTWD 115.3mTWD 175.6m
Dividends paid−TWD 80.8m−TWD 101.0m−TWD 202.0m−TWD 156.5m−TWD 151.5m−TWD 171.7m−TWD 120.1m−TWD 161.6m−TWD 161.6m−TWD 60.2m

Latest quarters

By quarter end

Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
RevenueTWD 529.6mTWD 517.2mTWD 523.8mTWD 541.7mTWD 579.5mTWD 579.2mTWD 579.9mTWD 512.3m
Operating incomeTWD 70.8mTWD 63.4mTWD 53.0mTWD 78.1mTWD 95.3mTWD 94.3mTWD 85.8mTWD 56.5m
Net incomeTWD 32.0mTWD 73.3mTWD 46.6mTWD 51.9mTWD 72.0mTWD 86.5mTWD 58.1mTWD 44.1m
Diluted earnings per share0.320.730.460.520.720.850.570.44
Cash from operationsTWD 32.0mTWD 179.0mTWD 50.0mTWD 94.0mTWD 138.0mTWD 194.0mTWD 132.0mTWD 62.0m
Capital spending−TWD 84.0m−TWD 53.0m−TWD 33.0m−TWD 148.0m−TWD 45.0m−TWD 250.0m−TWD 25.0m−TWD 181.0m
Free cash flow−TWD 52.0mTWD 126.0mTWD 17.0m−TWD 54.0mTWD 93.0m−TWD 56.0mTWD 107.0m−TWD 119.0m
Total assetsTWD 3.87bnTWD 3.82bnTWD 3.78bnTWD 3.81bnTWD 3.86bnTWD 3.81bnTWD 3.54bnTWD 3.63bn
Cash and short-term investmentsTWD 327.3mTWD 345.7mTWD 268.3mTWD 314.1mTWD 367.5mTWD 303.4mTWD 230.7mTWD 244.6m
DebtTWD 509.3mTWD 656.0mTWD 698.7mTWD 606.9mTWD 606.3mTWD 638.1mTWD 509.7mTWD 428.9m
Shareholders' equityTWD 2.36bnTWD 2.48bnTWD 2.43bnTWD 2.38bnTWD 2.33bnTWD 2.42bnTWD 2.33bnTWD 2.27bn

Financial ratios

Data as of 21 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin13.7%14.0%10.3%21.4%13.4%13.0%
Net margin11.3%11.1%9.2%18.1%11.0%10.5%
Return on equity9.8%10.1%8.3%14.6%8.8%8.3%
Return on assets6.4%6.4%5.1%9.8%5.7%5.6%
Free cash flow yield14.7%14.6%10.8%11.6%17.5%4.7%
Revenue growth-1.7%2.3%10.8%9.0%1.4%-0.4%
Earnings growth0.2%22.7%-43.6%79.5%6.9%-15.7%
Current ratio1.40x1.27x1.20x1.58x1.39x1.51x
Debt to equity0.26x0.26x0.25x0.17x0.24x0.22x
Equity ratio65.0%63.5%61.6%67.3%65.3%67.6%
Interest coverage34.41x55.84x30.73x85.88x67.43x52.85x
R&D as a share of sales7.8%7.7%7.6%7.4%7.5%9.1%
Buybacks as a share of market value1.0%-0.4%0.2%0.2%-0.1%-0.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.7%4.3%3.6%
Operating income-10.9%5.6%3.4%
Net income-11.5%5.9%2.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin13.8%15.2%14.7%13.8%
Net margin11.2%12.3%11.8%11.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings15.317.127.118.419.921.919.430.820.218.7
Price to sales1.71.92.53.32.22.32.42.02.52.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 20 Jun 2023.

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Paid in the year2.301.551.501.200.301.601.001.194
  • 1.07-for-1 split · 23 Sept 2014
  • 1.05-for-1 split · 17 Sept 2013
  • 11-for-10 split · 6 Oct 2008
  • 1.13-for-1 split · 17 Sept 2007
  • 11-for-10 split · 9 Nov 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.